BPA Call 36C24121A0063-36C24122N0243
Award Date 2/1/22
Potential Completion Date 7/31/22
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Providence, RI 02908, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Luminex Corporation is for the delivery of Luminex reagents under a Blanket Purchase Agreement (BPA) call. The contract, with a ceiling value of $164,760.47, was awarded on August 1, 2021 by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA). The contract is not set aside and is for COVID-19 related requirements, as indicated by the National Interest Action Code. Luminex is a manufacturer of biological...
- Luminex Corp has been awarded a Blanket Purchase Agreement (BPA) call valued at $92,743.36 for luminex reagents under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract, executed on August 1, 2024, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order from Veterans Integrated Service Network 1 (VISN 1), the Department of Veterans Affairs' regional network serving veterans across multiple northeastern states....
- This federal contract award is for LUMINEX REAGENTS, provided to the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs. The $89,432.32 firm fixed price contract was awarded to Luminex Corp, a manufacturer of in-vitro diagnostic testing technologies, on August 1, 2023. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has no set-aside designation and is expected...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a $506,839 delivery order to Luminex Corporation under its GSA Schedule 65-VII contract for invitro diagnostics, reagents, and tests. The delivery order is for Luminex reagents to support COVID-19 testing efforts and runs from April 23, 2020 through April 22, 2021. Luminex will provide the reagents on a firm-fixed-price basis from its facility in Butler, Pennsylvania to assist VA-VHA...
- This is a federal contract award from the Veterans Integrated Service Network 1 (VISN 1), a civilian agency, to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract, valued at $95,000.00, is for the provision of LUMINEX REAGENTS. It is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and an ultimate completion date of July 31, 2026. The contract is not designated as a set-aside. Luminex Corp, the prime contractor,...
- Luminex Corporation was awarded a $463,944.32 delivery order against the General Services Administration (GSA) Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The firm fixed price order is for the delivery of Luminex SAR2 test kits to support COVID-19 testing efforts and has a period of performance through November 11, 2021. No set-aside designation was used for this...
- Luminex Corporation was awarded a $90,282 firm fixed price contract by the Department of Veterans Affairs to provide VERIGENE brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2020 under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, with an end date of September 30, 2021. As the prime contractor, Luminex will deliver test kits and related materials to support clinical operations at the VA...
- This is a $125,000.00 firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The award does not have a set-aside designation. Luminex has provided diagnostic testing products, including COVID-19 test kits, to the Department of Veterans Affairs as well as other federal agencies such as the Defense Logistics...
- The Department of Veterans Affairs issued a BPA call to Luminex Corp for PCR testing services with a ceiling value of $532,050.05, awarded July 1, 2023. The call falls under the GSA Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits and supports the VA Pittsburgh Healthcare System. Place of performance is Pittsburgh, Pennsylvania. The call period of performance extends through June 30, 2024. Luminex specializes in multiplex diagnostic solutions, including testing...
- Luminex Corporation was awarded a $132,000 firm fixed price contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to provide COVID-19 testing supplies and equipment. The contract was awarded under the Multiple Award Schedule contracting vehicle to support the agency's response to the coronavirus pandemic. No set-aside provisions were applied to this award for COVID-19 related products and services. Performance will occur in...